abs

학술발표회초록보기

초록문의 abstract@kcsnet.or.kr

결제문의 member@kcsnet.or.kr

현재 가능한 작업은 아래와 같습니다.
  • 01월 01일 09시 이후 : 초록수정 불가능, 일정확인 및 검색만 가능

Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression; Transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway

등록일
2006년 2월 24일 17시 51분 22초
접수번호
1238
발표코드
금21E4심 이곳을 클릭하시면 발표코드에 대한 설명을 보실 수 있습니다.
발표시간
금 15시 : 30분
발표형식
심포지엄
발표분야
의약화학 - 의약1. Development of Carbohydrate-Based Drugs
저자 및
공동저자
김철호
성균관대학교 생명과학과,

The simple ganglioside GM3 increases cyclin-dependent kinase (CDK) inhibitor (CKI) p21WAF1 expression through the accumulation of p53 protein by the PTEN-mediated inhibition of the PI-3K/AKT/MDM2 survival signaling in HCT116 colon cancer cells. GM3 induces p53-dependent transcriptional activity of p21WAF1, as evidenced by the p21WAF1 promoter-driven luciferase reporter plasmid (full-length p21WAF1 promoter and a construct lacking the p53 binding sites). Additionally, ganglioside GM3 enhanced expression of CKI p27kip1 through the PTEN-mediated inhibition of the PI-3K/AKT signaling. Furthermore, the down-regulation of the cyclin E and CDK2 was clearly observed in GM3-treated HCT116 cells, but the down-regulation of cyclin D1 and CDK4 was not. Whereas, suppression of PTEN levels by RNA interference restores the enhanced expression of p53-dependent p21WAF1 and p27 kip1 through inactivation of PTEN-mediated PI-3K/AKT signaling by ganglioside GM3. We conclude that GM3 represents a modulator of cancer cell proliferation and may have potential for use in colorectal cancer therapy.


상단으로